tiprankstipranks
Nufarm Limited (AU:NUF)
ASX:NUF
Want to see AU:NUF full AI Analyst Report?

Nufarm Limited (NUF) AI Stock Analysis

68 Followers

Top Page

AU:NUF

Nufarm Limited

(Sydney:NUF)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - Gpt-5.6Sol)
Rating:50Neutral
Price Target:
AU$3.00
▼(-2.91% Downside)
Action:Reiterated
Date:06/25/26
Overall score reflects primary pressure from financial performance (declining revenue, negative profitability and ROE, and sharply weaker free cash flow). Technicals are mixed but somewhat supportive over longer horizons, while valuation metrics are undermined by a negative P/E and no provided dividend yield.
Positive Factors
Diversified global crop-protection platform
Nufarm operates across several essential crop-protection categories and geographic markets, giving it multiple avenues to serve growers and distributors. This breadth can support durable market access and reduce reliance on one product type or agricultural region over the next several quarters.
Negative Factors
Revenue contraction and unprofitable operations
The sharp revenue decline shows weaker commercial performance, while the negative net margin means current sales are not translating into bottom-line earnings. Persistent contraction would reduce reinvestment capacity, weaken returns from the operating platform and make recovery dependent on restoring demand and efficiency.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified global crop-protection platform
Nufarm operates across several essential crop-protection categories and geographic markets, giving it multiple avenues to serve growers and distributors. This breadth can support durable market access and reduce reliance on one product type or agricultural region over the next several quarters.
Read all positive factors

Nufarm Limited (NUF) vs. iShares MSCI Australia ETF (EWA)

Nufarm Limited Business Overview & Revenue Model

Company Description
Nufarm Limited, alongside its affiliated entities, specializes in the development, production, and global distribution of agricultural crop protection products and seed technologies. Its operations span key regions including Europe, the Middle Eas...
How the Company Makes Money
Nufarm primarily makes money by selling crop protection products into agricultural markets, generating revenue from the commercial sale of branded and off-patent/"post‑patent" active-ingredient-based products that are formulated and distributed fo...

Nufarm Limited Earnings Call Summary

Earnings Call Date:Nov 18, 2025
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Nov 19, 2026
Earnings Call Sentiment Neutral
The earnings call highlights a strong performance in Crop Protection and a strategic repositioning in Seed Technologies. However, significant losses from material items and challenges in the omega-3 market offset these positives. The company is focusing on debt reduction and operational improvements for future growth.
Positive Updates
Strong Crop Protection Performance
Crop Protection delivered a strong result with an 18% increase in earnings and profitability growth across all regions. EBITDA margin improved by 140 basis points.
Negative Updates
Statutory Loss Due to Material Items
A statutory loss of $165 million was reported, including $142 million of mainly non-cash material items related to the Seed Technology review and performance improvement program.
Read all updates
Q4-2025 Updates
Negative
Strong Crop Protection Performance
Crop Protection delivered a strong result with an 18% increase in earnings and profitability growth across all regions. EBITDA margin improved by 140 basis points.
Read all positive updates
Company Guidance
During the Nufarm Limited FY '25 Results Conference Call, several key metrics and strategic directions were highlighted. The company reported a statutory loss of $165 million, influenced by $142 million in non-cash material items and a broader performance improvement program. Despite this, Crop Protection saw an 18% increase in earnings, with an EBITDA margin improvement of 140 basis points and growth across all regions. Net debt was reduced by $538 million, ending with a leverage ratio of 2.7x. The company anticipates strong EBITDA growth in FY '26, targeting a leverage of 2.0x and planning for capital expenditure below $200 million. Seed Technologies underwent a strategic review, resulting in a reprioritized strategy aimed at enhancing shareholder value, focusing on profitable hybrid seeds, a reduction in omega-3 cash requirements, and expansion in bioenergy with BP. The outlook for FY '26 includes continued growth in Crop Protection, a $30 million improvement in emerging platforms' EBITDA, and a commitment to strong cost and capital deployment discipline.

Nufarm Limited Financial Statement Overview

Summary
Weak fundamentals: revenue fell 17.87%, net margin is negative (-4.80%), and ROE is negative (-7.83%). Cash generation also deteriorated with free cash flow down 47.08%, though leverage remains moderate (debt-to-equity 0.62) and gross margin is still reasonable (27.59%).
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
50
Neutral
BreakdownTTMSep 2025Sep 2024Sep 2023Sep 2022Jul 2021
Income Statement
Total Revenue4.20B3.44B3.35B3.48B3.77B3.22B
Gross Profit1.27B950.13M840.37M1.03B972.59M834.71M
EBITDA325.23M158.37M263.77M427.18M421.60M359.18M
Net Income-137.77M-165.32M-5.60M111.14M107.44M65.13M
Balance Sheet
Total Assets4.80B4.58B4.43B4.63B4.66B4.37B
Cash, Cash Equivalents and Short-Term Investments358.05M474.72M463.56M410.96M585.70M724.22M
Total Debt1.59B1.30B1.10B1.26B931.87M1.04B
Total Liabilities2.74B2.47B2.22B2.32B2.51B2.25B
Stockholders Equity1.82B1.86B2.21B2.31B2.15B2.12B
Cash Flow
Free Cash Flow-1.88M41.17M219.43M-352.36M160.20M281.70M
Operating Cash Flow97.53M162.76M472.39M-125.62M359.57M424.19M
Investing Cash Flow-196.36M-245.61M-207.46M-241.73M-240.41M-146.30M
Financing Cash Flow110.98M83.87M-200.76M185.98M-264.37M19.18M

Nufarm Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3.09
Price Trends
50DMA
2.94
Positive
100DMA
2.77
Positive
200DMA
2.49
Positive
Market Momentum
MACD
0.09
Negative
RSI
61.40
Neutral
STOCH
73.13
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NUF, the sentiment is Positive. The current price of 3.09 is above the 20-day moving average (MA) of 3.09, above the 50-day MA of 2.94, and above the 200-day MA of 2.49, indicating a bullish trend. The MACD of 0.09 indicates Negative momentum. The RSI at 61.40 is Neutral, neither overbought nor oversold. The STOCH value of 73.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:NUF.

Nufarm Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
AU$854.82M20.6119.51%1.17%16.85%70.12%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
54
Neutral
AU$339.98M-57.25-3.71%6.76%
50
Neutral
AU$1.23B-8.37-6.30%2.02%-1.53%-281.84%
49
Neutral
AU$18.93M-3.71-52.55%-11.34%30.34%
43
Neutral
AU$19.98M-2.16-88.51%-0.48%-195.74%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:NUF
Nufarm Limited
3.24
0.91
39.06%
AU:CP8
Canadian Phosphate
0.13
0.07
140.38%
AU:WGN
Wagners Holding Co. Ltd.
4.28
1.72
67.38%
AU:TGH
Terragen Holdings Ltd
0.02
<0.01
50.00%
AU:RLF
RLF AgTech Ltd
0.03
-0.02
-46.30%
AU:PLA
Pacific Lime and Cement Limited
0.40
0.14
51.92%

Nufarm Limited Corporate Events

Nufarm Reports Lapse of 191,399 Performance Rights
Jul 14, 2026
Nufarm Limited has reported the lapse of 191,399 performance rights, which ceased on 30 June 2026 after the conditions attached to these rights were not met or became incapable of being satisfied. The cessation slightly reduces Nufarm&#8217;s pote...
Nufarm Issues Nearly 2 Million Unquoted Performance Rights Under Incentive Plan
Jul 13, 2026
Nufarm Limited has notified the market of the issue of 1,990,618 unquoted performance rights under its employee incentive scheme, with an issue date of June 30, 2026. The new securities are not intended to be quoted on the ASX, highlighting Nufarm...
Nufarm Seeks ASX Quotation for New Shares Issued Under Employee Incentive Plan
Jul 10, 2026
Nufarm Limited has applied for quotation on the ASX of 103,643 new ordinary fully paid shares issued on July 6, 2026. These securities arise from an employee incentive scheme and will be quoted despite not being subject to transfer restrictions.Th...
Nufarm Updates Market on Director Rico Christensen’s Equity Interests
Jul 10, 2026
Nufarm Limited has disclosed a change in the interests of director Rico Christensen in the company&#8217;s securities, as required under ASX listing rules. The update covers both his direct holdings of ordinary shares and indirect interests held t...
Nufarm director Alexandra Gartmann lifts stake in on-market share purchase
Jul 3, 2026
Nufarm Limited has reported a change in director shareholdings, confirming that director Alexandra Gartmann increased her direct interest in ordinary shares. The transaction reflects the company&#8217;s adherence to ASX listing rules on disclosure...
Nufarm Director Tripodi Lifts Indirect Stake Through On-Market Share Buys
Jun 9, 2026
Nufarm Limited has disclosed a change in the interests of director Federico Tripodi, who increased his indirect holding in the company through on-market share purchases. Tripodi acquired a total of 21,800 fully paid ordinary shares via accounts he...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 25, 2026